Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-08 Sale | 2023-05-10 9:32 pm | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 66,730 | $0.1255 | $8,375 | 97,516 (Direct) | View |
| 2023-05-08 Sale | 2023-05-10 9:31 pm | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 68,014 | $0.1255 | $8,536 | 285,128 (Direct) | View |
| 2023-05-08 Sale | 2023-05-10 9:31 pm | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 38,531 | $0.1255 | $4,836 | 91,469 (Direct) | View |
| 2023-05-08 Sale | 2023-05-10 9:31 pm | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 3,537 | $0.1255 | $444 | 58,512 (Direct) | View |
| 2023-01-23 Sale | 2023-01-23 5:35 pm | Evelo Biosciences Inc. | EVLO | CARRIERE STEPHEN J Principal Accounting Officer | 151 | $1.0604 | $160 | 1,266 (Direct) | View |
| 2022-05-27 Purchase | 2022-06-01 7:00 pm | Evelo Biosciences Inc. | EVLO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner | 27,397,259 | $1.46 | $39,999,998 | 27,233,921 (Indirect) | View |
| 2022-05-27 Purchase | 2022-05-31 4:15 pm | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 34,246 | $1.46 | $49,999 | 34,246 (Direct) | View |
| 2022-05-27 Purchase | 2022-05-31 4:11 pm | Evelo Biosciences Inc. | EVLO | Darzi Lord Ara Director | 342,465 | $1.46 | $499,999 | 342,465 (Direct) | View |
| 2022-05-27 Purchase | 2022-05-31 4:07 pm | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 17,123 | $1.46 | $25,000 | 84,080 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-07 Exercise(A) | 2023-05-10 5:11 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 23,437 | $0 | 351,563 (Direct) | View |
| 2023-05-07 Exercise | 2023-05-09 4:09 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 130,000 | $0 | 520,000 (Direct) | View |
| 2023-05-07 Exercise | 2023-05-09 4:09 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 23,437 | $0 | 413,612 (Direct) | View |
| 2023-05-07 Exercise | 2023-05-09 4:08 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 132,500 | $0 | 750,642 (Direct) | View |
| 2023-05-07 Exercise | 2023-05-09 4:08 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 130,000 | $0 | 554,246 (Direct) | View |
| 2023-04-14 Option Award | 2023-04-18 5:12 pm | N/A 2033-04-14 | Evelo Biosciences Inc. | EVLO | Rosiello Robert L. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:38 pm | N/A 2033-02-07 | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 1,500,000 | $0 | 1,500,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:32 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 530,000 | $0 | 530,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:28 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 520,000 | $0 | 520,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:25 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 520,000 | $0 | 520,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 4:10 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Plinio Mark D. Chief Commercial Officer | 1,250 | $0.88 | 3,750 (Direct) | View |
| 2023-01-19 Exercise | 2023-01-23 5:35 pm | N/A 2032-01-19 | Evelo Biosciences Inc. | EVLO | CARRIERE STEPHEN J Principal Accounting Officer | 354 | $0 | 1,266 (Direct) | View |
| 2022-07-19 Option Award | 2022-10-14 4:37 pm | N/A 2032-07-19 | Evelo Biosciences Inc. | EVLO | Char Daniel General Counsel | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-07-19 Option Award | 2022-10-14 4:32 pm | N/A 2032-07-19 | Evelo Biosciences Inc. | EVLO | Zung Jonathan B. Chief Development Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2022-07-29 Option Award | 2022-10-14 4:24 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Plinio Mark D. Chief Commercial Officer | 1,250 | $1.79 | 2,500 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-01 4:52 pm | N/A 2032-09-01 | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 440,000 | $0 | 440,000 (Direct) | View |
| 2022-06-30 Exercise | 2022-06-30 4:52 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,927 | $0 | 93,932 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:53 pm | N/A 2032-06-09 | Evelo Biosciences Inc. | EVLO | MELAS KYRIAZI THEO Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:50 pm | N/A 2032-06-09 | Evelo Biosciences Inc. | EVLO | McInnes Iain B. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:48 pm | N/A 2032-06-09 | Evelo Biosciences Inc. | EVLO | McHugh Julie Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:44 pm | N/A 2032-06-09 | Evelo Biosciences Inc. | EVLO | Hohneker John Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 4:41 pm | N/A 2032-06-10 | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:38 pm | N/A 2032-06-09 | Evelo Biosciences Inc. | EVLO | Darzi Lord Ara Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:35 pm | N/A 2032-06-09 | Evelo Biosciences Inc. | EVLO | Andres Juan Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2022-06-01 7:00 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. 10% Owner | 0 | $0 | 13,698,630 (Indirect) | View |
| 2022-05-31 Exercise | 2022-06-01 4:12 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,925 | $0 | 93,932 (Direct) | View |
| 2022-05-02 Exercise | 2022-05-02 4:03 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,926 | $0 | 76,809 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 5:41 pm | N/A 2032-04-01 | Evelo Biosciences Inc. | EVLO | Gutierrez-Ramos Jose-Carlos Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2022-04-05 5:36 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Gutierrez-Ramos Jose-Carlos Director | 0 | $0 | 10,000 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 5:32 pm | N/A 2032-04-01 | Evelo Biosciences Inc. | EVLO | Williams Tonya Director | 40,000 | $0 | 40,000 (Direct) | View |